96 related articles for article (PubMed ID: 11585105)
1. Association of trypsin-2 with activation of gelatinase B and collagenase-2 in human bronchoalveolar lavage fluid in vivo.
Prikk K; Maisi P; Sepper R; Stenman UH; Salo T; Sorsa T
Ann Med; 2001 Sep; 33(6):437-44. PubMed ID: 11585105
[TBL] [Abstract][Full Text] [Related]
2. Inhalation of organic dusts and lipopolysaccharide increases gelatinolytic matrix metalloproteinases (MMPs) in the lungs of heaves horses.
Nevalainen M; Raulo SM; Brazil TJ; Pirie RS; Sorsa T; McGorum BC; Maisi P
Equine Vet J; 2002 Mar; 34(2):150-5. PubMed ID: 11902757
[TBL] [Abstract][Full Text] [Related]
3. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
4. Proteomics: is it an approach to understand the progression of chronic lung disorders?
Sepper R; Prikk K
J Proteome Res; 2004; 3(2):277-81. PubMed ID: 15113104
[TBL] [Abstract][Full Text] [Related]
5. Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.
Lauhio A; Sorsa T; Srinivas R; Stenman M; Tervahartiala T; Stenman UH; Grönhagen-Riska C; Honkanen E
Ann Med; 2008; 40(4):312-20. PubMed ID: 18428024
[TBL] [Abstract][Full Text] [Related]
6. MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar fluid (BALF) of COPD horses.
Raulo SM; Sorsa T; Tervahartiala T; Pirilä E; Maisi P
Equine Vet J; 2001 Mar; 33(2):128-36. PubMed ID: 11266061
[TBL] [Abstract][Full Text] [Related]
7. Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease.
Sepper R; Konttinen YT; Ding Y; Takagi M; Sorsa T
Chest; 1995 Jun; 107(6):1641-7. PubMed ID: 7781360
[TBL] [Abstract][Full Text] [Related]
8. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.
Henry MT; McMahon K; Mackarel AJ; Prikk K; Sorsa T; Maisi P; Sepper R; Fitzgerald MX; O'Connor CM
Eur Respir J; 2002 Nov; 20(5):1220-7. PubMed ID: 12449177
[TBL] [Abstract][Full Text] [Related]
10. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis.
Maisi P; Prikk K; Sepper R; Pirilä E; Salo T; Hietanen J; Sorsa T
APMIS; 2002 Nov; 110(11):771-82. PubMed ID: 12588417
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen.
Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T
Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883
[TBL] [Abstract][Full Text] [Related]
12. Gelatinolytic and type IV collagenolytic activity in bronchiectasis.
Sepper R; Konttinen YT; Sorsa T; Koski H
Chest; 1994 Oct; 106(4):1129-33. PubMed ID: 7924484
[TBL] [Abstract][Full Text] [Related]
13. Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Winkler MK; Foldes JK; Bunn RC; Fowlkes JL
Am J Physiol Lung Cell Mol Physiol; 2003 Apr; 284(4):L557-65. PubMed ID: 12456387
[TBL] [Abstract][Full Text] [Related]
14. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma.
Prikk K; Maisi P; Pirilä E; Reintam MA; Salo T; Sorsa T; Sepper R
Lab Invest; 2002 Nov; 82(11):1535-45. PubMed ID: 12429813
[TBL] [Abstract][Full Text] [Related]
15. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.
Suga M; Iyonaga K; Okamoto T; Gushima Y; Miyakawa H; Akaike T; Ando M
Am J Respir Crit Care Med; 2000 Nov; 162(5):1949-56. PubMed ID: 11069839
[TBL] [Abstract][Full Text] [Related]
16. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
Torii K; Iida K; Miyazaki Y; Saga S; Kondoh Y; Taniguchi H; Taki F; Takagi K; Matsuyama M; Suzuki R
Am J Respir Crit Care Med; 1997 Jan; 155(1):43-6. PubMed ID: 9001287
[TBL] [Abstract][Full Text] [Related]
17. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin.
Varani J; Hattori Y; Chi Y; Schmidt T; Perone P; Zeigler ME; Fader DJ; Johnson TM
Br J Cancer; 2000 Feb; 82(3):657-65. PubMed ID: 10682680
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury.
Gushima Y; Ichikado K; Suga M; Okamoto T; Iyonaga K; Sato K; Miyakawa H; Ando M
Eur Respir J; 2001 Nov; 18(5):827-37. PubMed ID: 11757634
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
Keck T; Balcom JH; Fernández-del Castillo C; Antoniu BA; Warshaw AL
Gastroenterology; 2002 Jan; 122(1):188-201. PubMed ID: 11781293
[TBL] [Abstract][Full Text] [Related]
20. Concentration of tumor-associated trypsin inhibitor (TATI) in pleural effusions.
Klockars M; Pettersson T; Fröseth B; Selroos O; Stenman UH
Chest; 1990 Nov; 98(5):1159-64. PubMed ID: 2225961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
